Correlation
The correlation between EHC and TMO is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
EHC vs. TMO
Compare and contrast key facts about Encompass Health Corporation (EHC) and Thermo Fisher Scientific Inc. (TMO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EHC or TMO.
Performance
EHC vs. TMO - Performance Comparison
Loading data...
Key characteristics
EHC:
1.63
TMO:
-1.20
EHC:
2.31
TMO:
-1.85
EHC:
1.32
TMO:
0.78
EHC:
2.45
TMO:
-0.82
EHC:
9.25
TMO:
-2.11
EHC:
4.28%
TMO:
15.65%
EHC:
25.70%
TMO:
27.22%
EHC:
-99.73%
TMO:
-71.16%
EHC:
-2.32%
TMO:
-40.50%
Fundamentals
EHC:
$11.98B
TMO:
$148.60B
EHC:
$4.86
TMO:
$17.05
EHC:
24.47
TMO:
23.09
EHC:
2.17
TMO:
3.46
EHC:
5.55
TMO:
3.01
EHC:
$5.51B
TMO:
$42.90B
EHC:
$2.01B
TMO:
$17.83B
EHC:
$1.25B
TMO:
$10.60B
Returns By Period
In the year-to-date period, EHC achieves a 29.20% return, which is significantly higher than TMO's -24.27% return. Over the past 10 years, EHC has outperformed TMO with an annualized return of 15.18%, while TMO has yielded a comparatively lower 12.06% annualized return.
EHC
29.20%
4.88%
16.98%
41.72%
34.29%
16.78%
15.18%
TMO
-24.27%
-7.21%
-23.32%
-32.40%
-10.25%
3.21%
12.06%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EHC vs. TMO — Risk-Adjusted Performance Rank
EHC
TMO
EHC vs. TMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Encompass Health Corporation (EHC) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
EHC vs. TMO - Dividend Comparison
EHC's dividend yield for the trailing twelve months is around 0.56%, more than TMO's 0.41% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EHC Encompass Health Corporation | 0.56% | 0.51% | 0.90% | 1.34% | 1.72% | 1.35% | 1.59% | 1.69% | 1.98% | 2.28% | 3.36% | 2.03% |
TMO Thermo Fisher Scientific Inc. | 0.41% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% | 0.48% |
Drawdowns
EHC vs. TMO - Drawdown Comparison
The maximum EHC drawdown since its inception was -99.73%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for EHC and TMO.
Loading data...
Volatility
EHC vs. TMO - Volatility Comparison
Encompass Health Corporation (EHC) and Thermo Fisher Scientific Inc. (TMO) have volatilities of 11.57% and 11.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
EHC vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Encompass Health Corporation and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EHC vs. TMO - Profitability Comparison
EHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Encompass Health Corporation reported a gross profit of 693.10M and revenue of 1.46B. Therefore, the gross margin over that period was 47.6%.
TMO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported a gross profit of 4.24B and revenue of 10.36B. Therefore, the gross margin over that period was 40.9%.
EHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Encompass Health Corporation reported an operating income of 267.00M and revenue of 1.46B, resulting in an operating margin of 18.4%.
TMO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported an operating income of 1.72B and revenue of 10.36B, resulting in an operating margin of 16.6%.
EHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Encompass Health Corporation reported a net income of 151.50M and revenue of 1.46B, resulting in a net margin of 10.4%.
TMO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported a net income of 1.51B and revenue of 10.36B, resulting in a net margin of 14.5%.